and get StockInvest.us Premium Subscription for FREE
Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Atara Biotherapeutics Stock Price (Quote) NASDAQ:ATRA
$8.73 ( 5.18% ) Tuesday, 5th Jul 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $4.91 | $8.85 | Tuesday, 5th Jul 2022 ATRA stock ended at $8.73. This is 5.18% more than the trading day before Friday, 1st Jul 2022. During the day the stock fluctuated 10.15% from a day low at $8.03 to a day high of $8.85. |
| 90 days | $4.61 | $9.55 | |
| 52 weeks | $4.61 | $20.04 |
Historical Atara Biotherapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2022-07-05 | $8.08 | $8.85 | $8.03 | $8.73 | 1 295 578 |
| 2022-07-01 | $7.79 | $8.38 | $7.73 | $8.30 | 1 322 549 |
| 2022-06-30 | $7.42 | $7.86 | $7.21 | $7.79 | 1 870 714 |
| 2022-06-29 | $6.54 | $7.63 | $6.50 | $7.58 | 1 747 306 |
| 2022-06-28 | $7.11 | $7.15 | $6.51 | $6.55 | 768 664 |
| 2022-06-27 | $7.11 | $7.27 | $6.96 | $7.03 | 717 786 |
| 2022-06-24 | $7.40 | $7.68 | $7.09 | $7.31 | 2 360 140 |
| 2022-06-23 | $6.85 | $7.35 | $6.85 | $7.35 | 1 471 652 |
| 2022-06-22 | $6.26 | $7.06 | $6.18 | $6.80 | 1 063 351 |
| 2022-06-21 | $5.93 | $6.65 | $5.87 | $6.46 | 2 021 876 |
| 2022-06-17 | $5.12 | $6.07 | $5.12 | $5.87 | 3 060 445 |
| 2022-06-16 | $5.32 | $5.41 | $4.91 | $5.05 | 1 145 812 |
| 2022-06-15 | $5.21 | $5.63 | $5.16 | $5.55 | 1 086 342 |
| 2022-06-14 | $5.18 | $5.26 | $5.05 | $5.16 | 927 766 |
| 2022-06-13 | $5.08 | $5.14 | $4.92 | $5.07 | 1 004 488 |
| 2022-06-10 | $5.53 | $5.53 | $5.03 | $5.22 | 828 793 |
| 2022-06-09 | $5.80 | $5.85 | $5.66 | $5.67 | 1 137 877 |
| 2022-06-08 | $5.63 | $6.06 | $5.60 | $5.88 | 812 778 |
| 2022-06-07 | $5.09 | $5.70 | $5.05 | $5.67 | 1 261 487 |
| 2022-06-06 | $5.25 | $5.68 | $5.12 | $5.19 | 951 097 |
| 2022-06-03 | $4.80 | $5.16 | $4.77 | $5.14 | 1 355 787 |
| 2022-06-02 | $4.77 | $4.86 | $4.66 | $4.80 | 642 638 |
| 2022-06-01 | $5.26 | $5.33 | $4.66 | $4.83 | 1 195 367 |
| 2022-05-31 | $5.16 | $5.24 | $5.00 | $5.20 | 1 194 669 |
| 2022-05-27 | $4.89 | $5.23 | $4.79 | $5.21 | 940 708 |
| 2022-05-26 | $4.84 | $5.09 | $4.84 | $4.87 | 849 427 |
| 2022-05-25 | $4.70 | $4.99 | $4.65 | $4.84 | 872 726 |
| 2022-05-24 | $4.85 | $4.96 | $4.61 | $4.69 | 1 285 710 |
| 2022-05-23 | $5.25 | $5.33 | $4.84 | $4.98 | 1 493 269 |
| 2022-05-20 | $5.15 | $5.29 | $4.70 | $5.16 | 1 480 437 |
| 2022-05-19 | $5.15 | $5.35 | $5.00 | $5.16 | 1 303 875 |
| 2022-05-18 | $5.36 | $5.43 | $4.97 | $5.13 | 1 395 932 |
| 2022-05-17 | $5.49 | $5.64 | $5.37 | $5.59 | 1 298 878 |
| 2022-05-16 | $5.47 | $5.47 | $5.20 | $5.30 | 883 995 |
| 2022-05-13 | $5.38 | $5.67 | $5.24 | $5.48 | 1 283 738 |
| 2022-05-12 | $4.87 | $5.47 | $4.84 | $5.22 | 1 612 206 |
| 2022-05-11 | $5.63 | $5.76 | $4.99 | $5.00 | 1 267 112 |
| 2022-05-10 | $5.98 | $6.54 | $5.43 | $5.69 | 1 777 798 |
| 2022-05-09 | $6.72 | $6.93 | $5.55 | $5.72 | 1 402 271 |
| 2022-05-06 | $6.50 | $7.14 | $6.40 | $6.92 | 1 208 058 |
| 2022-05-05 | $7.21 | $7.29 | $6.68 | $6.82 | 1 109 357 |
| 2022-05-04 | $7.04 | $7.32 | $6.64 | $7.31 | 972 814 |
| 2022-05-03 | $6.79 | $7.10 | $6.74 | $7.04 | 539 838 |
| 2022-05-02 | $6.41 | $6.95 | $6.39 | $6.94 | 1 169 239 |
| 2022-04-29 | $6.67 | $6.80 | $6.31 | $6.36 | 1 125 947 |
| 2022-04-28 | $6.78 | $6.88 | $6.33 | $6.72 | 743 656 |
| 2022-04-27 | $6.68 | $6.84 | $6.59 | $6.61 | 641 508 |
| 2022-04-26 | $7.25 | $7.34 | $6.67 | $6.72 | 887 660 |
| 2022-04-25 | $7.22 | $7.37 | $7.04 | $7.29 | 734 809 |
| 2022-04-22 | $7.39 | $7.48 | $7.14 | $7.26 | 1 049 300 |
Atara Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for patients with severe and life-threatening diseases. Its products under development include EBV-CTL, which is Phase II clinical trials for the treatment of malignancies associated with Epstein Barr Virus (EBV), including EBV-associated post-transplant lymphoproliferative disorders; CMV-CTL that is in Phase II clinical trials for the treatme... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
